These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34037754)

  • 1. Sublobar resection with intraoperative brachytherapy versus sublobar resection alone for early-stage non-small-cell lung cancer: a meta-analysis.
    Chen E; Wang J; Jia C; Min X; Zhang H
    Interact Cardiovasc Thorac Surg; 2021 Aug; 33(3):377-384. PubMed ID: 34037754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of brachytherapy on local recurrence rates after sublobar resection: results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non-small-cell lung cancer.
    Fernando HC; Landreneau RJ; Mandrekar SJ; Nichols FC; Hillman SL; Heron DE; Meyers BF; DiPetrillo TA; Jones DR; Starnes SL; Tan AD; Daly BD; Putnam JB
    J Clin Oncol; 2014 Aug; 32(23):2456-62. PubMed ID: 24982457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sublobar versus lobar resection: current status.
    Narsule CK; Ebright MI; Fernando HC
    Cancer J; 2011; 17(1):23-7. PubMed ID: 21263263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sublobar resection with brachytherapy versus lobectomy for stage Ib nonsmall cell lung cancer.
    Birdas TJ; Koehler RP; Colonias A; Trombetta M; Maley RH; Landreneau RJ; Keenan RJ
    Ann Thorac Surg; 2006 Feb; 81(2):434-8; discussion 438-9. PubMed ID: 16427827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lobar and sublobar resection with and without brachytherapy for small stage IA non-small cell lung cancer.
    Fernando HC; Santos RS; Benfield JR; Grannis FW; Keenan RJ; Luketich JD; Close JM; Landreneau RJ
    J Thorac Cardiovasc Surg; 2005 Feb; 129(2):261-7. PubMed ID: 15678034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of adjuvant brachytherapy with sublobar resection on pulmonary function and dyspnea in high-risk patients with operable disease: preliminary results from the American College of Surgeons Oncology Group Z4032 trial.
    Fernando HC; Landreneau RJ; Mandrekar SJ; Hillman SL; Nichols FC; Meyers B; DiPetrillo TA; Heron D; Jones DR; Daly BD; Starnes SL; Hatter JE; Putnam JB
    J Thorac Cardiovasc Surg; 2011 Sep; 142(3):554-62. PubMed ID: 21724195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thirty- and ninety-day outcomes after sublobar resection with and without brachytherapy for non-small cell lung cancer: results from a multicenter phase III study.
    Fernando HC; Landreneau RJ; Mandrekar SJ; Hillman SL; Nichols FC; Meyers B; DiPetrillo TA; Heron DE; Jones DR; Daly BD; Starnes SL; Tan A; Putnam JB
    J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1143-51. PubMed ID: 21872277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is brachytherapy effective for local recurrence control in sublobar resections for non-small-cell lung cancer?
    Patrini D; Lawrence D; Adams B; Panagiotopoulos N
    Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):677-81. PubMed ID: 26319561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lobectomy, segmentectomy, or wedge resection for peripheral clinical T1aN0 non-small cell lung cancer: A post hoc analysis of CALGB 140503 (Alliance).
    Altorki N; Wang X; Damman B; Mentlick J; Landreneau R; Wigle D; Jones DR; Conti M; Ashrafi AS; Liberman M; de Perrot M; Mitchell JD; Keenan R; Bauer T; Miller D; Stinchcombe TE
    J Thorac Cardiovasc Surg; 2024 Jan; 167(1):338-347.e1. PubMed ID: 37473998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Results for Clinical Stage IA Lung Cancer: Comparing Lobectomy and Sublobar Resection.
    Subramanian M; McMurry T; Meyers BF; Puri V; Kozower BD
    Ann Thorac Surg; 2018 Aug; 106(2):375-381. PubMed ID: 29580779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraoperative (125)I Vicryl mesh brachytherapy after sublobar resection for high-risk stage I non-small cell lung cancer.
    Voynov G; Heron DE; Lin CJ; Burton S; Chen A; Quinn A; Santos R; Colonias A; Landreneau RJ
    Brachytherapy; 2005; 4(4):278-85. PubMed ID: 16344258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.
    Altorki NK; Yip R; Hanaoka T; Bauer T; Aye R; Kohman L; Sheppard B; Thurer R; Andaz S; Smith M; Mayfield W; Grannis F; Korst R; Pass H; Straznicka M; Flores R; Henschke CI;
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):754-62; Discussion 762-4. PubMed ID: 24280722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgeons' preference sublobar resection for stage I NSCLC less than 3 cm.
    Huang CS; Hsu PK; Chen CK; Yeh YC; Hsu HS; Shih CC; Huang BS
    Thorac Cancer; 2020 Apr; 11(4):907-917. PubMed ID: 32037690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sublobar resection versus lobectomy for stage IA non-small-cell lung cancer: A systematic review and meta-analysis of randomized controlled trials.
    Meldola PF; Toth OAS; Schnorrenberger E; Machado PG; Chiarelli GFC; Kracik JLS; de Carvalho CC; Lôbo MM; Gross JL
    Surg Oncol; 2023 Dec; 51():101995. PubMed ID: 37776757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraoperative brachytherapy following thoracoscopic wedge resection of stage I lung cancer.
    d'Amato TA; Galloway M; Szydlowski G; Chen A; Landreneau RJ
    Chest; 1998 Oct; 114(4):1112-5. PubMed ID: 9792585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer.
    Altorki N; Wang X; Kozono D; Watt C; Landrenau R; Wigle D; Port J; Jones DR; Conti M; Ashrafi AS; Liberman M; Yasufuku K; Yang S; Mitchell JD; Pass H; Keenan R; Bauer T; Miller D; Kohman LJ; Stinchcombe TE; Vokes E
    N Engl J Med; 2023 Feb; 388(6):489-498. PubMed ID: 36780674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic body radiation therapy versus sublobar resection for stage I NSCLC.
    Ackerson BG; Tong BC; Hong JC; Gu L; Chino J; Trotter JW; D'Amico TA; Torok JA; Lafata K; Chang C; Kelsey CR
    Lung Cancer; 2018 Nov; 125():185-191. PubMed ID: 30429018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis.
    El-Sherif A; Gooding WE; Santos R; Pettiford B; Ferson PF; Fernando HC; Urda SJ; Luketich JD; Landreneau RJ
    Ann Thorac Surg; 2006 Aug; 82(2):408-15; discussion 415-6. PubMed ID: 16863738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between sublobar resection and 125Iodine brachytherapy after sublobar resection in high-risk patients with Stage I non-small-cell lung cancer.
    Santos R; Colonias A; Parda D; Trombetta M; Maley RH; Macherey R; Bartley S; Santucci T; Keenan RJ; Landreneau RJ
    Surgery; 2003 Oct; 134(4):691-7; discussion 697. PubMed ID: 14605631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.